Search the Newsreel

Lensar Returns to Profit in Q2 on Strong Demand for ALLY Cataract System

Lensar, Inc. reported strong financial results for Q2 2026, returning to profit with $3.5 million in net income, up from a loss the previous year. The company saw an 18% increase in revenue to $16.5 million, driven by demand for its ALLY Robotic Cataract …

LENSAR (LNSR) swings to profit on $39.9M H1 net income and $10M merger fee

LENSAR (NASDAQ:LNSR) Posts Quarterly Earnings Results, Beats Expectations By $0.26 EPS

LENSAR (NASDAQ:LNSR) announced strong quarterly earnings, reporting $0.10 EPS, significantly beating analyst expectations of a ($0.16) loss. The company saw an 18% year-over-year revenue increase to $16.5 million, driven by growth in recurring and procedure revenues, and achieved a record adjusted EBITDA of $3.6 …

LENSAR Q2 Earnings Call Highlights

LENSAR reported strong second-quarter 2026 results with 18% revenue growth, driven by increasing adoption of its ALLY robotic laser cataract system. The company achieved its strongest quarterly adjusted EBITDA to date and saw significant increases in procedures and U.S. market share. LENSAR is focused …

Earnings call transcript: LENSAR beats on Q2 2026 profit, shares jump premarket

LENSAR Inc. reported strong Q2 2026 results, with adjusted earnings of $0.10 per share and revenue of $16.5 million, significantly beating analyst expectations. The company's stock jumped 16.85% premarket due to increased recurring revenue, procedure volume, and improved profitability, including a record adjusted EBITDA …

LENSAR earnings beat by $0.31, revenue topped estimates

LENSAR Q2 Revenue Rises 18% as Net Income Reaches $3.5 Million

LENSAR (LNSR) swings to Q2 2026 profit as revenue and ALLY usage climb

LENSAR, Inc. (LNSR) reported a significant swing to profit in Q2 2026, with net income of $3.5 million compared to a $1.8 million loss in the prior year, driven by an 18% increase in total revenue to $16.5 million. The company saw strong growth …

LENSAR (LNSR) shareholders back directors, auditor and annual say-on-pay at 2026 meeting

LENSAR, Inc. held its 2026 annual stockholders meeting where shareholders elected three Class III directors, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved executive compensation on an advisory basis. Stockholders also preferred an annual frequency for future say-on-pay votes, which …

Earnings Preview: LENSAR to Report Financial Results Pre-market on August 13

This article provides an earnings preview for LENSAR (NASDAQ: LNSR), which is scheduled to release its Q2 2024 financial results before the market opens on August 13, 2024. The company has a history of beating EPS estimates but missing revenue forecasts. Investors will be …

LENSAR Inc (LNSR) Stock News Today

This article provides current stock information for LENSAR Inc (LNSR), including its stock price, market capitalization, and P/E ratio. It indicates that more news regarding the company's stock, earnings, and analyst ratings will be available soon. The page serves as a hub for financial …

LENSAR to report Q2 2026 results, host conference call

LENSAR will release its second-quarter 2026 financial results before market open on August 13, 2026. The company's management will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. The webcast will be accessible via LENSAR's …

LENSAR sets robotic cataract laser webcast for Aug. 13

LENSAR (Nasdaq: LNSR) will release its second quarter 2026 financial results before the market opens on Thursday, August 13, 2026. The company will also host a conference call and webcast at 8:30 a.m. ET the same day to discuss the results, recent developments, and …

LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026

LENSAR, Inc. announced it will release its second quarter 2026 financial results before market open on Thursday, August 13, 2026. Management will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results, recent corporate highlights, and …

(LNSR) Volatility Zones as Tactical Triggers

This article analyzes Lensar Inc. (NASDAQ: LNSR), highlighting strong near-term sentiment amidst persistent mid and long-term weakness. It identifies a 96.5:1 risk-reward setup targeting a 37.0% gain with minimal risk, and provides AI-generated trading strategies including position trading, momentum breakout, and risk hedging with …

LENSAR (LNSR) Expected to Release Earnings on Thursday

LENSAR (NASDAQ:LNSR) is set to release its Q2 2026 earnings before the market opens on Thursday, August 6th. Analysts anticipate a loss of $0.165 per share on revenues of $14.65 million. The company previously reported strong Q1 results, beating earnings estimates significantly, and currently …

LENSAR, Inc. Revenue Breakdown – NASDAQ:LNSR

LENSAR, Inc. (NASDAQ:LNSR) generated $46.31 million in revenue last year, primarily from its LENSAR Laser System segment, which accounted for $45.93 million. The United States was the largest contributor to revenue, bringing in $41.09 million. These figures represent an increase from the previous year's …

LENSAR Inc (LNSR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for LENSAR Inc (LNSR), detailing its current risk score, beta value, and various metrics related to volatility, maximum drawdown, and liquidity. LENSAR Inc holds a risk assessment score of 4.05, placing it 110th out of 199 in the …

LENSAR Inc (LNSR) Institutional Confidence

This article analyzes the institutional confidence in LENSAR Inc (LNSR), noting its current score of 5.00 within the Healthcare Equipment & Supplies industry. Institutional shareholding has increased to 55.41%, with Bill Nygren | OAKMX identified as the largest institutional shareholder. The report also lists …

LNSR|LENSAR Inc|Price:5.370|

LENSAR Inc (LNSR) is a commercial-stage medical device company focused on advanced systems for cataract treatment, including its ALLY Robotic Cataract Laser Treatment System. The company's fundamentals are relatively healthy with high growth potential, and its valuation is considered fairly valued. Despite recent weak …

LNSR|LENSAR Inc|Price:5.260|Chg%:-0.090

This article provides a comprehensive stock analysis of LENSAR Inc (LNSR) by TradingKey, highlighting its robust fundamentals, high growth potential, and a "fairly valued" status within the Healthcare Equipment & Supplies industry. Despite recent weak stock market performance, the company shows strong fundamentals and …

LENSAR Inc (LNSR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of LENSAR Inc (LNSR), listing major shareholders by proportion and categorizing shareholder types. It also provides a historical overview of institutional shareholding data from 2023Q4 to 2026Q1, showing the number of institutions, shares held, and changes over time. …

LENSAR Inc (LNSR) Cash Flow

This article provides an in-depth look at LENSAR Inc.'s cash flow statements, including operating, investing, and financing activities, across various fiscal quarters. It presents detailed financial data, highlighting changes in cash flows and net income. Additionally, the article includes a Q&A section explaining key …

LENSAR receives certification for new adaptive cataract treatment system

LENSAR, Inc. has received EU Medical Device Regulation (MDR) certification for its ALLY Adaptive Cataract Treatment System, enabling its commercialization in the European Union. This system is the first cataract laser to use artificial intelligence for iris registration and astigmatism management, aiming to improve …

LENSAR Inc (LNSR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of LENSAR Inc (LNSR)'s dividend and stock split history. It states that the company has distributed $0.00 in dividends over the past five years and shows "No Data" for specific dividend dates. The article includes current stock trading information …

LENSAR Inc (LNSR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for LENSAR Inc (LNSR), detailing its financial performance by region. As of April 6, the company's regional revenue shows the United States as its largest market, contributing 66.43% of total revenue. Other significant regions include Europe and Asia …

LENSAR Inc (LNSR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of LENSAR Inc (LNSR), noting its current valuation score of 9.29, which ranks 27th in the Healthcare Equipment & Supplies industry. The company's P/E ratio is 2.29, significantly above its recent low but below its recent high. Other …

LENS stock trades on Nasdaq as investors weigh cataract device growth and recent financial trends

LENSAR Inc. (LENS) stock is trading on Nasdaq, reflecting investor interest in the ophthalmic device maker specializing in femtosecond laser systems for cataract surgery. The company is in a growth phase, showing modest but growing revenues alongside recurring operating losses due to significant R&D …

LNSR Earnings Overview 2026-06-01 - Analyst Drop Coverage

Lensar (LNSR) Q4 2025 Earnings Transcript

LENSAR® Reports First Quarter 2026 Results and Provides Business Update

LENSAR ($LNSR) Releases Q4 2025 Earnings, Stock Rises

Lensar Stock Loses 48% This Week Despite BTIG Upgrade To Buy